Diasorin operates in the market for in vitro diagnostics. It produces and distributes reagents to test fluid specimens taken from patients (blood, urine, etc.) in a laboratory setting.The products developed and distributed by the Diasorin Group are designed specifically for clinical diagnostics applications.

They are used by diagnostic laboratories that are part of hospital facilities or operate independently (private diagnostic services laboratories). For the most part, they help physicians in diagnosing different diseases (diagnostic benefit), determining the progress of a disease (prognostic benefit) and assessing the effectiveness of a drug treatment (monitoring benefit).